Naloxon B. Braun (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxon B. Braun, is an opioid antagonist presented as a sterile solution for injection for intramuscular and intravenous use. It rapidly reverses the effects of opioid overdose in adults and children. GNH USA supplies Naloxon B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naloxone is an opioid antagonist used to treat acute opioid overdose and related emergencies. - Acute opioid overdose: rapidly restores breathing and consciousness in patients with life‑threatening opioid toxicity. - Opioid‑induced respiratory depression: reverses severe respiratory depression caused by opioid drugs. - Opioid toxicity in emergency settings: provides prompt antagonism of mu‑opioid receptors to counteract overdose effects.

Naloxone may cause a range of adverse reactions after administration.

Common Side Effects: - Injection site pain - Nausea - Sweating

Serious or Rare Side Effects: - Acute pulmonary edema - Cardiac arrhythmias - Anaphylactic reaction

Naloxon B. Braun should be used with careful clinical monitoring. - Assess respiratory status before administration: confirm need for opioid reversal. - Monitor cardiovascular function after reversal: watch for hypertension or arrhythmias. - Use with caution in opioid‑dependent patients: abrupt reversal can precipitate withdrawal. - Adjust dosing in pediatric patients as directed by the prescriber. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Naloxon B. Braun can interact with several drug classes.

Major Interactions (Avoid): - Concurrent potent opioid agonists may reduce reversal efficacy. - Use with mixed agonist‑antagonist opioids (e.g., buprenorphine) can precipitate severe withdrawal. - Co‑administration with vasopressors may mask hypotension.

Moderate Interactions (Monitor Closely): - Sedatives or CNS depressants may still cause respiratory depression after naloxone. - MAO inhibitors may increase the risk of hypertension. - Antihypertensive agents may potentiate blood pressure fluctuations.